Hemopoietic Growth Factors and Oncogenes in Myeloid Leukemia Development

  • D. Metcalf
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 31)

Abstract

Understanding of the abnormal nature of cancer cells has advanced rapidly in the past decade because of work in two apparently separate fields — those of oncogenes and specific growth-regulatory factors. What has intrigued workers in both fields has been the recognition that, in a number of instances, the products of oncogenes or proto-onco-genes have been shown to be related either to growth factors themselves or to the receptors for such growth factors. The reported examples of this association are already numerous enough to make a chance association improbable — c-sis and PDGF [1], c-erb-B and the EGF receptor [2], c-fms and the CSF-1 receptor [3]. When this association is considered in the light of the numerous documented examples, particularly in the leukemias and lymphomas, of non-random chromosomal translocations that involve proto-oncogenes [4], a strong case exists for formalizing earlier notions of cancer into a concept that neoplastic change results from aberrant or aberrantly expressed genes that code for growth factors or growth factor receptors.

Keywords

Hydrate Lymphoma Leukemia Anemia Disulfide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Johnson A, Heldin C-H, Wasteson A, Westermark B, Deuel TF, Huang JS, Seeburg PH, Gray A, Ullrich A, Scrace G, Stroobant P, Waterfield MD (1984) The c-sis gene encodes a precursor of the B chain of platelet-derived growth factor. EMBO J 3:921–928Google Scholar
  2. 2.
    Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tarn AW, Lee J, Yarden Y, Liebermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression in the amplified gene in A431 epidermal carcinoma cells. Nature 309:418–425PubMedCrossRefGoogle Scholar
  3. 3.
    Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER (1985) The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocytic growth factor CSF-1. Cell 41:665–676PubMedCrossRefGoogle Scholar
  4. 4.
    Cory S (1986) Activation of cellular onco-genes in hemopoietic cells by chromosome translocation. Adv Cancer Res 47:189–234PubMedCrossRefGoogle Scholar
  5. 5.
    Metcalf D (1986) The molecular biology and functions of the granuloeyte-macrophage colony-stimulating factors. Blood 67:257–267PubMedGoogle Scholar
  6. 6.
    Gough NM, Gough J, Metcalf D, Kelso A, Grail D, Nicola NA, Burgess AW, Dunn AR (1984) Molecular cloning of cDNA encoding a murine haemopoietic growth regulator, granuloeyte-macrophage colony-stimulating factor. Nature 309:763–767PubMedCrossRefGoogle Scholar
  7. 7.
    Fung MC, Hapel AJ, Ymer S, Cohen DR, Johnson RN, Campbell HD, Young IG (1984) Molecular cloning of cDNA for mouse interleukin-3. Nature 307:233–237PubMedCrossRefGoogle Scholar
  8. 8.
    Yokota T, Lee F, Rennick D, Hall C, Arai N, Mosmann T, Nabel G, Cantor H, Arai K (1984) Isolation and characterization of a mouse cDNA clone that expresses mast cell growth factor in monkey cells. Proc Natl Acad Sci (USA) 81:1070–1074CrossRefGoogle Scholar
  9. 9.
    Wong GG, Witek J, Temple PA, Wilkens KM, Leary AC, Luxenberg DF, Jones SS, Brown EC, Kay RM, Orr EC, Shoemaker C, Golde DW, Kaufman RJ, Hewick RM, Wang EA, Clark SC (1985) Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 228:810–815PubMedCrossRefGoogle Scholar
  10. 10.
    Nagata S, Tsuchiya A, Asano S, Kaziro Y, Yamazaki T, Yamamoto O, Hirata Y, Kubota N, Oheda M, Nomura H, Ono M (1986) Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319:415–418PubMedCrossRefGoogle Scholar
  11. 11.
    Souza LM, Boone TC, Gabrilove J, Lai PH, Zsebo KM, Murdock DC, Chazin VR, Braszewski J, Lu H, Chen KK, et al. (1986) Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells. Science 232:61–65PubMedCrossRefGoogle Scholar
  12. 12.
    Kawasaki ES, Ladner MB, Wang AM, Arsdell J Van, Warren MK, Coyne MY, Schweickart VL, Lee M-T, Wilson KJ, Boosman A, Stanley ER, Ralph P, Mark DF (1985) Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). Science 230:291–296PubMedCrossRefGoogle Scholar
  13. 13.
    Walker F, Nicola NA, Metcalf D, Burgess AW (1985) Hierarchical down-modulation of hemopoietic growth factor receptors. Cell 43:269–276PubMedCrossRefGoogle Scholar
  14. 14.
    Nicola NA, Begley CG, Metcalf D (1985) Identification of the human analogue of a regulator that induces differentiation in mu-rine leukaemic cells. Nature 314:625–628PubMedCrossRefGoogle Scholar
  15. 15.
    Metcalf D (1984) The hemopoietic colony-stimulating factors. Elsevier, AmsterdamGoogle Scholar
  16. 16.
    Metcalf D (1982) Regulatory control of the proliferation and differentiation of normal and leukemia cells. Natl Cancer Inst Monogr 60:123–131PubMedGoogle Scholar
  17. 17.
    Metcalf D (1979) Clonal analysis of the action of GM-CSF on the proliferation and differentiation of myelomonocytic leukemic cells. Int J Cancer 24:616–623PubMedCrossRefGoogle Scholar
  18. 18.
    Metcalf D, Nicola NA (1982) Autoinduction of differentiation in WEHI-3B leukemia cells. Int J Cancer 30:773–780PubMedCrossRefGoogle Scholar
  19. 19.
    Metcalf D (1980) Clonal extinction of myelomonocytic leukemic cells by serum from mice injected with endotoxin. Int J Cancer 25:225–233PubMedCrossRefGoogle Scholar
  20. 20.
    Metcalf D (1982) Regulator-induced suppression of myelomonocytic leukemic cells: clonal analysis of early cellular events. Int J Cancer 30:203–210PubMedCrossRefGoogle Scholar
  21. 21.
    Nicola NA, Metcalf D (1984) Binding of the differentiation-inducer, granulocyte colony-stimulating factor to responsive but not unresponsive leukemic cell lines. Proc Natl Acad Sci USA 81:3765–3769PubMedCrossRefGoogle Scholar
  22. 22.
    Hapel AJ, Lee JC, Farrar WC, Ihle JN (1981) Establishment of continuous cultures of Thy 1.2+ Ly 1+ 2 T cells with purified interleukin-3. Cell 25:179–186PubMedCrossRefGoogle Scholar
  23. 23.
    Schrader JW, Crapper RM (1983) Autogenous production of a hemopoietic growth factor “P-cell-stimulating factor” as a mechanism for transformation of bone marrow-derived cells. Proc Natl Acad Sei USA 80:6892–6896CrossRefGoogle Scholar
  24. 24.
    Lang RA, Metcalf D, Gough NM, Dunn AR, Gonda TJ (1985) Expression of a hemato-poietic growth factor cDNA in a factor-dependent cell line results in autonomous growth and tumorigenicity. Cell 43:531–542PubMedCrossRefGoogle Scholar
  25. 25.
    Cook WD, Metcalf D, Nicola NA, Burgess AW, Walker F (1985) Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell 41:677–683PubMedCrossRefGoogle Scholar
  26. 26.
    Pierce JH, Di Fiore PP, Aaronson SA, Potter M, Pumphrey J, Scott A, Ihle JN (1985) Neoplastic transformation of mast cells by Abelson MuLV: abrogation of IL-3 dependence of a nonautocrine mechanism. Cell 41:685–693PubMedCrossRefGoogle Scholar
  27. 27.
    Muller R, Curren T, Muller D, Guilbert L (1985) Induction of c-fos during myelomonocytic differentiation and macrophage proliferation. Nature 314:546–548PubMedCrossRefGoogle Scholar
  28. 28.
    Weinberg RA (1985) The action of oncogenes in the cytoplasm and nucleus. Science 230:770–776PubMedCrossRefGoogle Scholar
  29. 29.
    Heubner K, Isobe M, Croce CM, Golde DW, Kaufman SE, Gasson JC (1985) The human gene encoding GM-CSF is at 5q 21-q32 the chromosome region deleted in the 5q anomaly. Science 230:1282–1285CrossRefGoogle Scholar
  30. 30.
    Le Beau MM, Westbrook CA, Diaz MO, Larson RA, Rowley JD, Gasson JL, Golde DW, Sherr CJ (1986) Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders. Science 231:984–987PubMedCrossRefGoogle Scholar
  31. 31.
    Lotem J, Lipton JH, Sachs L (1980) Separation of different molecular forms of macrophage- and granulocyte-inducing proteins for normal and leukemic myeloid cells. Int J Cancer 25:763–771PubMedCrossRefGoogle Scholar
  32. 32.
    Yamamoto Y, Tomida M, Hozumi M (1980) Production by spleen cells of factors stimulating differentiation of mouse myeloid leukemic cells that differ from colony-stimulating factor. Cancer Res 40:4804–4809PubMedGoogle Scholar
  33. 33.
    Olssen I, Sarngadharan MG, Breitman TR, Gallo RC (1984) Isolation and characterization of a T-lymphocyte-derived differentiation-inducing factor for the myeloid leukemic cell line HL-60. Blood 63:510–517Google Scholar
  34. 34.
    Lotem J, Sachs L (1985) Control of in vivo differentiation of myeloid leukemia cells. V. Regulation by response to antigen. Leuk Res 9:1479–1486PubMedCrossRefGoogle Scholar
  35. 35.
    Tomida M, Yamamoto-Yamiguchi Y, Hozumi M (1984) Purification of a factor inducing differentiation of mouse myeloid leukemic Ml cells from conditioned medium of mouse fibroblast L929 cells. J Biol Chem 259:10978–10982PubMedGoogle Scholar
  36. 36.
    Lotem J, Sachs L (1984) Control of in vivo differentiation of myeloid leukemic cells. IV. Inhibition of leukemia development by myeloid differentiation-inducing protein. Int J Cancer 33:147–154PubMedCrossRefGoogle Scholar
  37. 37.
    Lotem J, Sachs L (1983) Coupling of growth and differentiation in normal myeloid precursors and the breakdown of this coupling in leukemia. Int J Cancer 32:127–134PubMedCrossRefGoogle Scholar
  38. 38.
    Nicola NA, Metcalf D, Matsumoto M, Johnson GR (1983) Purification of a factor inducing differentiation in murine myelomo-nocytic leukemia cells. Identification as granulocyte colony-stimulating factor (G-CSF). J Biol Chem 258:9017–9023PubMedGoogle Scholar
  39. 39.
    Symonds G, Sachs L (1982) Autoinduction of differentiation in myeloid leukemic cells: restoration of normal coupling between growth and differentiation in leukemia cells that con-stitutively produce their own growth-inducing protein. EMBO J 1:1343–1346PubMedGoogle Scholar
  40. 40.
    Metcalf D, Nicola NA (1985) Role of the colony-stimulating factors in the emergence and suppression of myeloid leukemia populations. In: Wahren B et al. (eds) Molecular biology of tumor cells. Raven, New York, pp 215–232Google Scholar
  41. 41.
    Buick RN, Minden MD, McCulloch EA (1979) Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia. Blood 54:95–104PubMedGoogle Scholar
  42. 42.
    Nara N, McCulloch EA (1986) A comparison of the growth-supporting capacities of fresh and cultured leukemic blast cells. Leuk Res 10:273–277PubMedCrossRefGoogle Scholar
  43. 43.
    Abraham J, Rovera G (1981) Inducers and inhibitors of leukemic cell differentiation in culture. In: Baserga R (ed) Tissue growth factors. Springer-Verlag, Berlin Heidelberg New York, pp 405–425CrossRefGoogle Scholar
  44. 44.
    Boyd AW, Metcalf D (1984) Induction of differentiation in HL60 cells: a cell cycle-dependent all-or-none effect. Leuk Res 8:27–43PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • D. Metcalf
    • 1
  1. 1.Cancer Research UnitWalter and Eliza Hall InstituteAustralia

Personalised recommendations